HAMILTON, BERMUDA , Aug. 03, 2022 (GLOBE NEWSWIRE) --
HAMILTON, BERMUDA -- August 3, 2022 -- Altamira Therapeutics ("Altamira" or the "Company") (NASDAQ:CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, today announced that its Founder, Chairman and Chief Executive Officer, Thomas Meyer, participated in a video interview with Proactive Investors to discuss the Company’s corporate strategy and its key advantages, catalysts, and market opportunities as it advances towards becoming an RNA therapeutics pure play. Mr. Meyer also discussed the planned divestiture or spin-off of its legacy businesses.
Read more at globenewswire.com